CASI Pharmaceuticals Reaches Analyst Target Price
October 13, 2017 at 08:21 AM EDT
In recent trading, shares of CASI Pharmaceuticals, Inc. (CASI) have crossed above the average analyst 12-month target price of $3.50, changing hands for $3.64/share..